Log in or Sign up for Free to view tailored content for your specialty!
Psychiatry News
No correlation found between depression, self-reported disability in MS
WEST PALM BEACH, Fla. — No correlation was found between depression and self-report of disability in a small group of patients with multiple sclerosis, according to a poster from ACTRIMS 2024.
Q&A: US ‘should end seasonal clock change’ by adopting permanent standard time
This Sunday, most Americans will adjust their clocks 1 hour to “spring forward” into daylight saving time, at which time they will lose an hour of sleep but gain an hour of daylight.
Log in or Sign up for Free to view tailored content for your specialty!
Better sleep linked to improved verbal memory in multiple sclerosis
WEST PALM BEACH, Fla. — In two separate cohorts of individuals with multiple sclerosis and memory issues, better sleep was linked to improved verbal memory, according to a poster at ACTRIMS 2024.
Higher BMI linked to worse depressive symptoms among middle-aged and older adults
Adults with a higher BMI and waist-to-hip ratio may be more likely to report worse depression, according to study findings published in PLOS ONE.
Patients with depression may have increased rates of complications after TKA
SAN FRANCISCO — Results presented here showed patients with depression undergoing total knee arthroplasty experienced an increased risk of medical and surgical complications, readmissions and reoperations.
Repetitive transcranial magnetic stimulation alleviates psychomotor slowing from psychosis
Three weeks of 1-Hz repetitive transcranial magnetic stimulation effectively alleviated psychomotor slowing among people with schizophrenia spectrum disorder, according to a study published in JAMA Psychiatry.
Study: US school shootings more deadly since 1997
Mass shootings on school campuses in the United States have become more deadly over the last 25 years, according to a study published in Pediatrics.
FDA grants breakthrough device designation to blood-based Alzheimer’s diagnostic assay
The FDA has granted breakthrough device designation to a phospho-tau 217 blood-based biomarker to assist in the diagnosis of Alzheimer’s disease, according to the manufacturer.
Depression risk elevated in both seropositive, seronegative rheumatoid arthritis
Patients with rheumatoid arthritis — either seropositive or seronegative — demonstrate a 1.66-fold higher risk for depression vs. healthy controls, according to data published in JAMA Network Open.
Positive results announced in phase 2 trial of psilocybin for generalized anxiety disorder
Incannex Healthcare has announced positive topline results from its phase 2 PsiGAD1 clinical trial of psilocybin for generalized anxiety disorder, reporting statistically significant improvement in anxiety scores compared with placebo.